Full-Time
Director of Business Development
Confirmed live in the last 24 hours
AI-driven drug discovery as a service
Senior
San Francisco, CA, USA
- Bachelor’s degree required, advanced degree preferred, preferably in life sciences, chemistry, computational sciences, business or marketing.
- 8+ years of experience in business development with a record of accomplishment in leading and executing transactions in lab services or software sales.
- General awareness of drug discovery process, challenges, and trends within the industry.
- Good business instincts with fluency in business analytics and valuation methodologies
- Proven ability to drive business decisions, while managing multiple projects effectively.
- Superior oral communication, written and presentations skills with demonstrated self-awareness when engaging clients and prospects.
- Identify, evaluate, and transact new opportunities that align with TandemAI’s software, computations, and wet lab services platform to drive revenue growth.
- Identify and engage new clients by networking with leaders in biotech, pharma and venture capitalist firms through conferences, hosted gatherings, and other external events.
- Support new client interactions through meeting organization, confidentiality documentation and SOW creation in collaboration with TandemAI legal.
- Support and manage current TandamAI clients through business and operational interactions.
- Support negotiations and / or negotiate for TandemAI in all business interactions with current and future clients.
- Provide prosecting and BD updates, as well as sales projections to leadership on a routine basis.
TandemAI is a respected leader in the drug discovery sector, providing researchers with a cutting-edge platform that merges AI with physics-based tools alongside a robust super-computing infrastructure and extensive wet lab facilities. This unique integration enables a streamlined and efficient drug development process, making it an exemplary workplace for individuals passionate about leveraging technology to advance healthcare solutions. The company's commitment to democratizing next-generation computational aided drug design with tools like TandemViz™ 1.0 ensures continuous learning and innovation within a nourishing team environment.
Company Stage
Series A
Total Funding
$60M
Headquarters
New York, New York
Founded
2021